Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of SOX9 (unknown origin) expressed in African green monkey COS7 cells assessed as reduction in SOX9 transcriptional activity at
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of SOX9 in HUVEC assessed as reduction of SOX9-SOX9 interactions up to 200 uM incubated for 45 mins by Alpha-screen assay
Inhibition of SOX9 in HUVEC assessed as reduction of SOX9-SOX9 interactions incubated for 45 mins by Alpha-screen assay
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW620)
Assay data:15 Active, 794 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNUC5)
Assay data:11 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCT15)
Assay data:18 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (CAR1)
Assay data:9 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT55)
Assay data:20 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (RCM1)
Assay data:13 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT29)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNUC1)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (LS513)
Assay data:16 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (NCIH630)
Assay data:17 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCC56)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW48)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT115)
Assay data:14 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (DIFI)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (COLO678)
Assay data:22 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNU407)
Assay data:12 Active, 794 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on